Latest Cadence Pharmaceuticals Inc. Stories

2014-02-28 16:23:53

SAN DIEGO, Feb. 28, 2014 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today reported financial results for the three and twelve months ended December 31, 2013. Recent highlights included: -- Cadence entered into an agreement and plan of merger agreement with Mallinckrodt plc and one of its wholly owned...

2014-02-11 16:25:57

SAN DIEGO, Feb. 11, 2014 /PRNewswire/ -- Shareholder rights attorneys at Robbins Arroyo LLP are investigating the proposed acquisition of Cadence Pharmaceuticals, Inc. (NASDAQ: CADX) by Mallinckrodt plc (NYSE: MNK). On February 11, 2014, the two companies announced the signing of a definitive agreement pursuant to which a subsidiary of Mallinckrodt will commence a tender offer to acquire all outstanding shares of Cadence stock for $14.00 per share in cash. (Logo:...

2014-02-11 12:26:40

NEW YORK, Feb. 11, 2014 /PRNewswire/ -- Bernstein Liebhard LLP is investigating whether the Board of Directors of Cadence Pharmaceuticals, Inc. ("Cadence Pharmaceuticals" or the "Company") (NASDAQ: CADX) breached its fiduciary duty to its shareholders in agreeing to sell Cadence Pharmaceuticals to Mallinckrodt plc. (Logo: http://photos.prnewswire.com/prnh/20120202/MM47134LOGO) Under the terms of the agreement, Cadence Pharmaceuticals shareholders will receive $14.00 in cash for...

Word of the Day
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.